Along these lines, recent work in cancer cells has shown that p53 activity and stability can be enhanced by acetylation at the Lysine373 residue (and possibly Lysine382 residue) on the C-terminal of the p53 protein, which leads to enhanced susceptibility of cells to stress [26]–[30]. Here, TP53 is linked to cancer.